Schedule 13D ownership disclosure
AGEX THERAPEUTICS INC
Security class unavailable · CUSIP: 00848H108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 21,208,914
- Percent of class
- 50.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-089055
- Form type
- SC 13D
- Filer
- Serina Therapeutics, Inc.
- CIK
- CIK 1708599
- Filed
- Jul 31, 2020
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership